SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 148 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $28 | +27.3% | 28,305 | 0.0% | 0.00% | – |
Q1 2023 | $22 | +69.2% | 28,305 | -18.5% | 0.00% | – |
Q4 2022 | $13 | -99.9% | 34,751 | -1.7% | 0.00% | – |
Q3 2022 | $16,000 | -50.0% | 35,352 | -13.7% | 0.00% | – |
Q2 2022 | $32,000 | -54.9% | 40,948 | -25.6% | 0.00% | – |
Q1 2022 | $71,000 | +14.5% | 55,026 | +13.1% | 0.00% | – |
Q4 2021 | $62,000 | -73.8% | 48,651 | -55.3% | 0.00% | – |
Q3 2021 | $237,000 | -51.4% | 108,904 | -16.3% | 0.00% | – |
Q2 2021 | $488,000 | +19.0% | 130,104 | +3.5% | 0.00% | – |
Q1 2021 | $410,000 | -2.4% | 125,692 | +2.0% | 0.00% | – |
Q4 2020 | $420,000 | -20.6% | 123,251 | -4.9% | 0.00% | – |
Q3 2020 | $529,000 | +11.8% | 129,648 | -7.4% | 0.00% | – |
Q2 2020 | $473,000 | +50.6% | 139,947 | +3.9% | 0.00% | – |
Q1 2020 | $314,000 | +61.0% | 134,638 | +151.5% | 0.00% | – |
Q4 2019 | $195,000 | -56.0% | 53,527 | +0.2% | 0.00% | – |
Q3 2019 | $443,000 | -0.7% | 53,408 | +3.1% | 0.00% | – |
Q2 2019 | $446,000 | -18.6% | 51,791 | +0.9% | 0.00% | – |
Q1 2019 | $548,000 | +23.7% | 51,305 | +1.2% | 0.00% | – |
Q4 2018 | $443,000 | +19.7% | 50,674 | +130.3% | 0.00% | – |
Q3 2018 | $370,000 | -17.0% | 22,003 | +3.3% | 0.00% | – |
Q2 2018 | $446,000 | +53.8% | 21,300 | +18.2% | 0.00% | – |
Q1 2018 | $290,000 | -13.4% | 18,015 | +1.9% | 0.00% | – |
Q4 2017 | $335,000 | -8.5% | 17,686 | -32.0% | 0.00% | – |
Q3 2017 | $366,000 | +88.7% | 26,016 | 0.0% | 0.00% | – |
Q2 2017 | $194,000 | +9.6% | 26,016 | -4.4% | 0.00% | – |
Q1 2017 | $177,000 | +47.5% | 27,200 | 0.0% | 0.00% | – |
Q4 2016 | $120,000 | -5.5% | 27,200 | 0.0% | 0.00% | – |
Q3 2016 | $127,000 | -29.1% | 27,200 | 0.0% | 0.00% | – |
Q2 2016 | $179,000 | +3.5% | 27,200 | 0.0% | 0.00% | – |
Q1 2016 | $173,000 | +5.5% | 27,200 | 0.0% | 0.00% | – |
Q4 2015 | $164,000 | – | 27,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |